C4 Therapeutics CCCC
NASDAQ CCCC
$2.89 -0.11 (-3.67%)
At close: Nov 11, 2026 · 4:00 PM EST

C4 Therapeutics (CCCC) Short term Debt (2022 - 2023)

Updated

C4 Therapeutics' Short term Debt came in at $10.34 million for Q2 2023, compared with $750,000 a year earlier and up 351.9% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Short term Debt (2022 - 2023) Analysis & Trends

At the end of FY2022, C4 Therapeutics' Short term Debt was $2.29 million.

  • Business Quant data shows CCCC's Short term Debt at $2.29 million (Q1 2023), $2.29 million (Q4 2022) and $2.25 million (Q3 2022) in the three quarters before Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 C4 Therapeutics 393.93 Mn -549.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 10.34 Mn
Mar 31, 2023 2.29 Mn
Dec 31, 2022 2.29 Mn
Sep 30, 2022 2.25 Mn
Jun 30, 2022 750,000.00
Mar 31, 2022 750,000.00
API Access

C4 Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CCCC&period=max&api_key=YOUR_API_KEY